FDA Approved: MIACALCIN — Supplemental Application (Mylan Institutional LLC)

View source ↗

Summary

The FDA approved a supplemental application for Miacalcin (calcitonin salmon) submitted by Mylan Institutional LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercalcemia
• Osteoporosis
• Paget Disease of Bone

Drugs mentioned

• MIACALCIN (Calcitonin salmon)

Snippet

SUPPL AP for MIACALCIN (CALCITONIN SALMON)